COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD ZincZn
HC Q study #30
Source   PDF   Share   Tweet
See all 155 studies
Late treatment study
Alberici et al., Kidney Int., 98:1, 20-26, July 1, 2020, doi:10.1016/j.kint.2020.04.030 (preprint 5/10) (Peer Reviewed)
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection
Analysis of 94 hemodialysis COVID-19 positive patients. Reduction in death seen with HC Q but p=0.12, OR 0.44 [0.16–1.24].
death, ↓42.9%, p=0.12
(odds ratio converted to relative risk)
Source   PDF   Share   Tweet
See all 155 studies
Please send us corrections, updates, or comments.